Group 1 - The core viewpoint of the article highlights that Chongqing Kaici Medical Technology Co., Ltd. has successfully completed a multi-million RMB financing round aimed at mass production and market expansion of its full magnetic suspension products, as well as accelerating its multi-line R&D process [1] - The company was established in 2023 and focuses on innovation and breakthroughs in full magnetic suspension motor technology, gathering top research talents and industry teams in this field [2] - Kaici Medical's core technology is full magnetic suspension technology, which features contactless, wear-free, high precision, and low noise characteristics. The company has overcome significant technical challenges and has applied for over 70 patents, with more than 40 granted [3] Group 2 - The company has developed a full magnetic suspension artificial heart (blood pump) that is used in various medical devices, including ventricular assist devices, ECMO systems, and extracorporeal circulation machines [3] - Additionally, Kaici Medical has created low-shear, stable-output full magnetic suspension stirrers and clean pumps, achieving series production with numerous models to meet the needs of biopharmaceutical processes from upstream fermentation to downstream purification [5] - These products address issues related to traditional technologies, such as contamination and low cell viability, while also overcoming limitations of high prices, long lead times, and high usage costs associated with imported products [5]